-transparent.png){kind=logo}
An immunoglobulin specific for RNase [EC 3.1.4.22] has been synthesized in a cell-free system containing either lymph node microsomes or polysomes or spleen polysomes from rats previously immunized with RNase. The synthesis of anti-RNase immunoglobulin was demonstrated by affinity chromatography using an RNase-Sepharose column. Supporting evidence for the cell-free synthesis of immunoglobulin was obtained by separating the synthesized immunoglobulin from other proteins by DEAE-Sephadex A-25 column chromatography and by neutralization of RNase activity with the separated immunoglobulin. Lymph nodes and spleen had an almost equal capacity to synthesize the immunoglobulin to RNase. Under our experimental conditions, 5 to 15 per cent of the total protein synthesis was directed toward immunoglobulin synthesis.
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
January 1978,
Journal of immunological methods,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
February 1981,
Journal of biochemistry,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
April 1972,
The Biochemical journal,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
January 1983,
Analytical biochemistry,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
December 1980,
Journal of biochemistry,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
April 1976,
The Journal of biological chemistry,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
December 1969,
European journal of biochemistry,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
January 2002,
Immunological investigations,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
June 2009,
Current pharmaceutical biotechnology,
K Igarashi, and
K Terada, and
Y Tango, and
K Katakura, and
S Hirose
January 1982,
Leukemia research,
